Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 526 |
Allworth Financial
Folsom,
California
| $243M | -$36.8M | 121 | 1.03% | Reduced |
|
| 527 |
Todd Asset Management
Louisville,
Kentucky
| $242M | -$37.9M | 10 | 4.31% | Reduced |
|
| 528 |
BAMCO Inc
New York
| $240M | -$9.39M | 14 | 0.36% | Reduced |
|
| 529 |
Sarasin & Partners
London,
United Kingdom
| $240M | -$129M | 3 | 2.81% | Reduced |
|
| 530 |
Exchange Traded Concepts
Oklahoma City,
Oklahoma
| $237M | +$79.2M | 18 | 1.08% | Increased |
|
| 531 |
Vident Advisory
Alpharetta,
Georgia
| $236M | +$36.1M | 29 | 1.71% | Increased |
|
| 532 |
TLP
Tri Locum Partners
New York
| $234M | +$43.6M | 4 | 28.75% | Increased |
|
| 533 |
EFG International
Zurich,
| $233M | +$29.5M | 27 | 4.27% | Increased |
|
| 534 |
Crossmark Global Holdings
Houston,
Texas
| $232M | +$25M | 27 | 3.01% | Increased |
|
| 535 |
Saudi Central Bank
Riyadh,
Saudi Arabia
| $232M | +$65.8M | 11 | 3.04% | Increased |
|
| 536 |
OCA
Octagon Capital Advisors
New York
| $230M | -$30M | 7 | 20.68% | Reduced |
|
| 537 |
Yousif Capital Management
Bloomfield Hills,
Michigan
| $230M | -$22.9M | 24 | 2.57% | Reduced |
|
| 538 |
Schonfeld Strategic Advisors
New York
| $228M | +$42.8M | 58 | 0.82% | Increased |
|
| 539 |
Sequoia Financial Advisors
Akron,
Ohio
| $227M | +$6.85M | 34 | 1.13% | Increased |
|
| 540 |
Advisors Asset Management
Monument,
Colorado
| $226M | -$8.03M | 20 | 3.45% | Reduced |
|
| 541 |
ZWJ Investment Counsel
Atlanta,
Georgia
| $226M | +$4.53M | 7 | 7.31% | Increased |
|
| 542 |
Cannell & Spears
New York
| $226M | -$50.4M | 11 | 4.01% | Reduced |
|
| 543 |
Kennedy Capital Management
St Louis,
Missouri
| $225M | +$5.44M | 26 | 3.98% | Increased |
|
| 544 |
Savant Capital
Rockford,
Illinois
| $223M | +$74.7M | 23 | 0.66% | Increased |
|
| 545 |
Benjamin Edwards Inc
Clayton,
Missouri
| $223M | +$13.9M | 17 | 2.03% | Increased |
|
| 546 |
Ethic Inc
New York
| $221M | +$20.2M | 22 | 2.76% | Increased |
|
| 547 |
CCM
Catalio Capital Management
New York
| $221M | +$58.6M | 13 | 41.55% | Increased |
|
| 548 |
Concurrent Investment Advisors
Tampa,
Florida
| $219M | +$34.3M | 25 | 1.86% | Increased |
|
| 549 |
Union Bancaire Privee
Geneva 1,
Switzerland
| $219M | -$222K | 12 | 2.39% | Reduced |
|
| 550 |
Parnassus Investments
San Francisco,
California
| $219M | +$11.3M | 5 | 0.58% | Increased |
|